HOLLAND LANDING, Ontario, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Inscape (TSX: INQ) announced voting results from its 2018 annual meeting of shareholders ("the meeting") held on September 12, 2018.
The total number of votes represented at the meeting is 42,177,275 being 94.79% of the total 44,493,630 votes attached to Class B Subordinated Voting Shares and Class A Multiple Voting Shares.
The following directors were elected until the next annual meeting of Shareholders unless their office is terminated earlier or their office is vacated in accordance with the Company's by-laws.
Name of Nominee
Votes For
% For
Votes Withheld
% Withheld
Bartley Bull
42,172,464
100%
1
0%
Brian Mirsky
42,170,923
100%
1,542
0%
David LaSalle
42,170,923
100%
1,542
0%
Dezsö J. Horváth
42,170,923
100%
1,542
0%
Eric Ehgoetz
42,170,923
100%
1,542
0%
Frank Delfino
42,170,923
100%
1,542
0%
Tania Bortolotto
42,170,923
100%
1,542
0%
About Inscape Inscape is a design enabler. We have been saying yes since 1888 with a versatile portfolio of systems, storage, and walls products that are adaptable, and always built to last. With a wide dealer network, showrooms in both Canada and the U.S., and full service and support for all of our clients, our philosophy is to always do what we can to say Yes.
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...